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PRELIMINARY STUDY TOWARDS A NOVEL EXPERIMENTAL MODEL TO STUDY LOCALIZED 
CUTANEOUS LEISHMANIASIS CAUSED BY Leishmania (Leishmania) mexicana
Erika Ivett SOSA-BIBIANO, Nicole Raymonde VAN WYNSBERGHE, Silvia Beatriz CANTO-LARA & Fernando Jose ANDRADE-NARVAEZ
SUMMARY
There is not an experimental model of localized cutaneous leishmaniasis (LCL) caused by Leishmania (Leishmania) mexicana. The 
aim of the present study was to characterize the clinical and histological features of Peromyscus yucatanicus experimentally infected 
with L. (L.) mexicana. A total of 54 P. yucatanicus (groups of 18) were inoculated with 1x106 promastigotes of L. (L.) mexicana in 
the base of the tail. They were euthanized at three and six months post experimental infection. The control group was inoculated 
with RPMI-1640. The predominant clinical sign observed was a single ulcerated lesion in 27.77% (5/18) and in 11.11% (2/18) P. 
yucatanicus at three and six months respectively. The histological pattern described as chronic granulomatous inflammation with or 
without necrosis was found in 7/7 (100%) biopsies of euthanized P. yucatanicus at three (n = 5) and six (n = 2) months, respectively. 
These results resembled clinical and histological features caused by L. (L.) mexicana in humans, and support the possibility to employ 
P. yucatanicus as a novel experimental model to study LCL caused by this parasite.
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INTRODUCTION
Localized cutaneous leishmaniasis (LCL) known as “chiclero´s ulcer” 
(collector of natural chewing gum) in southern Mexico, was described by 
Seidelin in 191231. Since then, the forest region of the Yucatan peninsula 
has been recognized as an endemic focus of LCL3,6,32. Leishmania 
(Leishmania) mexicana Biagi, 1953, emend. Garnham, 1962, is the main 
agent causing CL in this focus; however, L. (Viannia) braziliensis has 
also been isolated in a few cases9,10.
The clinical features of “chiclero´s ulcer” have been studied and it is 
characterized predominantly by cartilage involvement of the pinna of the 
ear7,16,39. The most frequently observed presentation is a single, ulcerated, 
rounded small lesion, with elevated borders and necrotic center, located 
on the ear, with an evolution time of less than three months, and with 
neither cutaneous metastases nor lymphatic nor mucosal involvement4. 
Criteria for scars resulting from healed lesions of humans with CL caused 
by Leishmania (Viannia) braziliensis include: no history of trauma, 
round or oval shape, smooth surface, depressed, and pigment change, 
hypopigmentation38. No differences have been observed in scars from 
LCL caused by L. (L.) mexicana (unpublished data).
The histopathology of LCL due to Leishmania (Leishmania) 
mexicana in the Yucatan Peninsula, Mexico, has also been described. 
Type III and IV of Magalhaes’ classification21 have been found as the 
most common patterns in 21/73 (28.7%) and 32/73 (43.8%) respectively 
of our LCL cases caused by L. (L.) mexicana5. 
The cutaneous leishmaniasis laboratory mouse model using C57BL/6 
(resistant) and BALB/c (susceptible) infected with L. major is the most 
employed system for analyzing the regulation of the immune response 
against this pathogen only contained by a cell-mediated response19,30. 
However, C57BL/6 mice inoculated with L. (L.) mexicana developed a 
chronic disease2. Although the L. major mouse model is considered by 
many to be the best small animal immunological model for CL, concern 
about its relevance suggests other models should be developed. In 
particular, because laboratory mice are usually reduced to homozygosity, 
are hybrids of three species (Mus musculus musculus, M. m. domesticus, 
M. m. castaneus)37 and are not natural reservoirs of leishmaniasis 
parasites, the use of other, wild-type species that are naturally infected 
should be considered as alternative models. 
In Campeche, three rodents have been identified as primary reservoirs 
of L. (L.) mexicana: Ototylomys phyllotis Merriam, 1901; Peromyscus 
yucatanicus J.A. Allen and Chapman, 1897; and Heteromys gaumeri J.A. 
Allen and Chapman, 189710,11,35,36. The two latter species are endemic in 
the Yucatan Peninsula. O. phyllotis and P. yucatanicus have been adapted 
to laboratory and a colony for experimental studies has been established 
at our institution, however the former has been rejected to be employed 
as an experimental model to study CL caused by L. (L.) mexicana14. The 
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use of local mammalian fauna as a model host to study the development 
of experimental Leishmania spp. infection could give a more approximate 
whole picture of what probably occurs in natural conditions12.
In order to develop a novel experimental model of LCL caused by L. 
(L.) mexicana we sought to characterize clinical and histological features 
of P. yucatanicus experimentally infected with L. (L.) mexicana as a 
fundamental first step for developing an infection model. 
MATERIALS AND METHODS
Animals: Six month old P. yucatanicus of both sexes were selected 
from the colony. The animals were maintained in the animal care facility 
of the Centro de Investigaciones Regionales, Universidad Autonóma de 
Yucataán (CIR, UADY). The mice were housed individually in small 
cages (19 x 29 x 12 cm) lined with wood shavings and fed ad libitum 
rodent chow (2018S Harlan, Madison, Wisconsin, USA). For enrichment 
and food balance, once a week the mice were given fresh fruit or 
vegetables. During the experiment, the animals were kept at 22 °C with 
a 12/12h light cycle. Physical enrichment was provided weekly in the 
form of cardboard tubes for hiding and paper for nesting material. All 
animals were euthanized with sodium pentobarbital 100 mg/kg, according 
to the Mexican Law for the use of laboratory animals, and the Guide for 
the Care and Use of Laboratory Animals13,29. The proposal was approved 
by the bioethics committee of CIR, UADY.
Parasite: Although the dose of Leishmania promastigotes delivered 
by the sand fly vector to the skin of mammalian host has never been 
directly determined, using a real time-PCR approach it has been possible 
to reveal a remarkable range of 10 to 100,000 in the dose of parasites 
transmitted to mice exposed to a single infected sand fly15. More recently, 
another study determined infection parameters in the sand fly vector 
that predict transmission of L. (L.) major: it was estimated in the range 
of 103 to 106 total parasites per fly34. Taking into account these studies 
we chose to inoculate 1x106 promastigotes to increase the possibility of 
inducing CL clinical signs.
Local strain MPERO/MX/97/Py4, isolated from a P. yucatanicus 
with clinical signs (ulcerated lesion), was identified by isoenzymes and 
monoclonal antibodies as L. (L.) mexicana and was selected for use in 
this study9,10. Its infectivity was restored by a passage in Syrian golden 
hamsters (Mesocricetus auratus). Promastigotes were grown in Senekjie’s 
medium for seven days at 23 ºC. Stationary-phase promastigotes were 
washed three times in RPMI-1640 medium (Gibco) before being counted 
and adjusted to a 1x106 concentration for inoculation at a final volume 
of 40 µL. All animals were inoculated in the base of the tail. 
Parasite demonstration: Based on previous studies in which local 
signs of infection by L. (L.) mexicana were always located at the base of 
the tail10,11,35,36, smears were made from samples collected at the edge of 
the lesion (avoiding ulcerated and/or heavily crusted parts) or from the 
inoculation site in absence of local signs. Moreover, smears were made 
from the liver and spleen samples. Furthermore, aspirates and cultures 
from the skin of the base of the tail in each animal were prepared. Liquid 
culture medium (0.1-0.2 mL RPMI 1640) with antibiotics were inoculated 
and aspirated repeatedly with an insulin needle (1 mL, 27G x 13mm) 
subcutaneously into base of the tail or at the margin of the lesion when 
it existed. The aspirates were cultured into tubes containing modified 
Senekjie’s medium, incubated at 23.5 oC and examined weekly by light 
microscope for parasite growth. A culture was considerate positive when 
at least one promastigote was observed and negative if no parasites were 
found. If negative, the procedure was repeated until three consecutive 
aspirates were found with one week intervals.
Experimental infection: A total of 54 P. yucatanicus in groups of 
18 animals were inoculated in the base of the tail and were euthanized at 
three (group I) and six (group II) months post experimental inoculation. 
Control group (III) was inoculated with RPMI-1640 and euthanized at 
three months. 
Clinical features: All animals were examined weekly for the 
following local clinical signs of infection including ulcerated lesion, 
crust and scar, which are the main documented symptoms in humans 
with LCL caused by L. (L.) mexicana4.
Histological features: Skin biopsies were taken from the edge of 
the lesion (avoiding ulcerated and/or heavily crusted parts) or from the 
inoculation site in absence of local signs with a 4-mm disposable punch 
and 2% xylocaine as an anesthetic just before euthanizing the animals. 
The material was fixed in neutral formalin, routinely processed and 
embedded in paraffin. Sections were stained with hematoxylin and 
eosin. Histopathological findings were grouped in patterns according 
to a classification proposed by MAGALHAES et al.21. The following 
five histopathological patterns were defined as having occurred and it 
has been done in CL patients infected with L. (L.) mexicana: type I) 
exudative-cellular reaction due to infiltration of histiocytes, lymphocytes, 
and plasma cells, without granuloma; type II) exudative-necrotic reaction, 
characterized by cellular infiltration, and necrosis and no granulomatous 
response; type III) exudative and necrotic-granulomatous reaction 
corresponding to the pattern described as chronic granulomatous 
inflammation with or without necrosis; type IV) exudative granulomatous 
reaction (unorganized granuloma) without necrosis characterized by the 
presence of an unorganized granulomatous reaction; type V) exudative 
tuberculoid reaction in which a typical tuberculoid granuloma (organized) 
is formed.
RESULTS
Clinical features: Local clinical signs were recorded for each one 
of the experimental groups inoculated with 1x106 promastigotes of L. 
(L.) mexicana. None of the P. yucatanicus inoculated with RMPI-1640 
developed clinical or histological features of Leishmania infection. 
Absence of local clinical signs was observed in a total of 29/36 (80.55%) 
of the P. yucatanicus experimentally inoculated including both groups 
I and II. At three months, Group I, the most common clinical sign was 
a single ulcerated lesion observed in 27.77% (5/18) P. yucatanicus that 
completed the study, within a range of eight to 10 weeks post experimental 
infection and persisting without healing during the whole period of 
survey. In P. yucatanicus followed for six months, Group II, only in 
2/18 (11.11%) ulcerated lesions and crusts were observed, and healing 
was recorded at week 17 and 18 respectively. Results regarding clinical 
features are shown in Table 1 and Figure 1. There was no difference in 
the course of the infection linked to P. yucatanicus gender.
Histological features: At three months the histological picture of 
Leishmania infection was characterized by pattern type III, i.e. exudative 
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and necrotic-granulomatous reactions corresponding to the pattern 
described as chronic granulomatous inflammation with or without 
necrosis were found in 7/7 (100%) biopsies of euthanized P. yucatanicus 
at three (n = 5) and six (n = 2) months respectively. Parasites were 
observed in all P. yucatanicus with local signs of infection.
Parasite demonstration: Smears from ulcerated lesions were all 
positive at three months post experimental inoculation and negative at six 
months (n = 6 and 2 respectively). Smears from the liver were positive 
in 11/18 (61.11%) at three months, and in 16/18 (88.88%) at six months. 
Smears from the spleen were 17/18 (94.44%) positive at three months 
and 12/18 (66.66%) positive at six months. Isolations and cultures from 
P. yucatanicus were positive in 61.11% (11/18) and 66.66% (12/18) at 
three and six months respectively. 
DISCUSSION
This is the first study that examines P. yucatanicus clinical and 
histological features of experimental infection with L. (L.) mexicana. As 
a preliminary study towards the development of a novel experimental 
model to study LCL caused by L. (L.) mexicana, a first and fundamental 
criterion was to document that both clinical and histological features 
resembled those described previously in humans with LCL caused by 
L. (L.) mexicana17.
In the present study the most common clinical sign, as reported in 
patients with LCL4, was a single, ulcerated, rounded small lesion, with 
elevated borders and necrotic center, observed in 7/36 (19.44%) of the 
P. yucatanicus experimentally infected with 1x106 L. (L.) mexicana 
promastigotes. Moreover, scars developed in P. yucatanicus gathered the 
criteria for healed lesions of humans with CL, i.e. round or oval shape, 
smooth surface, depressed, and hypopigmentation37. 
It must be remarked that absence of local clinical signs was observed 
in a total of 29/36 (80.55%) P. yucatanicus experimentally infected 
with 1x106 L. (L.) mexicana promastigotes. As described previously a 
criterion to incriminate a primary reservoir of Leishmania stated that 
the infection in a reservoir species should be relatively nonpathogenic, 
that is, the infection should not lower the survival possibility of the 
animal since it has to live until the next transmission season, which is 
more than seven months in the Peninsula. In other words, the immune 
system of the reservoir must react to the presence of the parasite in such 
a manner that while preventing irrevocable damage, the parasite evades 
sterilizing immunity36.
There was no difference in the course of the infection linked to 
P. yucatanicus gender. However we do not consider this finding to be 
conclusive regarding the possible role of sex as demonstrated in the 
mouse model33. More studies will be done regarding the role of sex in 
susceptibility and/or resistance to the infection by L. (L.) mexicana in 
P. yucatanicus.
The histological picture observed in P. yucatanicus experimentally 
infected with L. (L.) mexicana was predominantly type III with reference 
to Magalhaes’ classification whereas in patients with CL caused by the 
same Leishmania species it was type III and IV. Although a possible 
correlation between clinical and histological features has been examined 
to understand the immunological response in humans infected with L. 
(L.) mexicana5, it has been difficult to establish because such examination 
depends on a wide range of variables such as the host, the Leishmania 
species, the time of evolution at the moment of performing the histological 
study, the inoculation route and the dose of the parasite. 
Parasite isolation and culture from the skin of the base of the tail 
of P. yucatanicus was positive in 61.11% (11/18) and 66.66% (12/18) 
at three and six months, and in smears from the liver and the spleen. 
With reference to this finding L. major DNA was detected by PCR in 
the lymph nodes, spleens, bone marrow, and livers of C57BL/6 one 
year after recovery from infection1. Moreover DNA specific for L. (V) 
braziliensis was detected by PCR in scars after clinical cure of CL24. We 
have reported in a previous study the retention of L. (L.) mexicana in 29 
naturally infected rodents including six P. yucatanicus. These cricetids 
lived in captivity for up to two years and were tested monthly for the 
presence of the parasite by cultures of needle aspirates from the base of the 
tail35. These data support the persistence of the parasite in P. yucatanicus 
experimentally infected, as in the human treated or spontaneously healed 
and in the mouse model of CL.
Since the 1970s parasitic protozoa of the genus Leishmania have 
provided a useful perspective for immunologists in terms of host defense 
mechanisms critical for the resolution of infection caused by intracellular 
pathogens in experimental studies done in the mouse model. The 
paradigm for the CD4+ T-helper 1 (Th1)/Th2 dichotomy is largely based, 
Table 1
Local clinical signs developed by P. yucatanicus experimentally infected with 
1x106 promastigotes of Leishmania (Leishmania) mexicana
P. yucatanicus Group Ulcer Crust Scar
Py-9 3 months Weeks 8-12 Weeks 9-12
Py-10 3 months Weeks 9-12 Weeks 9-12
Py-11 3 months Weeks10-12 Weeks 9-12
Py-12 3 months - Weeks 9-12
Py-15 3 months Weeks 8-12 -
Py-16 3 months Weeks 10-12 Weeks 10-12
Py-42 6 months Weeks 8-10 Weeks 11-17 Weeks 18-24
Py-43 6 months Weeks 16-17 Weeks 16-17 Weeks 17-24
Fig. 1 - A: typical patient localized cutaneous nodular ulcerated lesion caused by L. (L.) 
mexicana; B: representative nodular ulcerated lesion from a P. yucatanicus experimentally 
infected with 1x106 promastigotes of L. (L.) mexicana.
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respectively, to the Leishmania major infection in a susceptible/resistant 
mouse model. Different virulence factors have been identified for distinct 
Leishmania species, and there are profound differences in the immune 
mechanisms that mediate susceptibility/resistance to infection and in 
the pathology associated with disease. These variations not only point to 
interesting features of the host-pathogen interaction and immunobiology 
of this genus of parasitic protozoa, but also have important implications 
for immunotherapy and vaccine development22.
A view of leishmaniasis that only considers mouse model 
infection with L. major misses a wealth of interesting immunobiology 
associated with other species of Leishmania. L. (L.) amazonensis and 
L. (L.) mexicana are associated with quite different patterns of disease 
following infection of mice when compared with L. major. For example, 
C57BL/6 or C3H mice, which heal from the L. major infection, develop 
chronic disease when infected with either L. (L.) amazonensis or L. (L.) 
mexicana2. Conflicting data may arise in part because different parasite 
strains or species are being examined, different tissue target (the mice’s 
footpad, the ear, or base of the tail) are being infected, and different doses 
(“low” 1x102 and “high” 1x106) of metacyclic promastigotes have been 
inoculated20,27,28. In addition immunological studies carried out in humans 
did not reproduce the Th1/Th2 dichotomy described in the L. major, 
C57BL/6 and the BALB/c mouse model of CL18,23,24. In summary there 
is not an experimental model to study LCL caused by L. (L.) mexicana. 
Although classical laboratory mice have advantages, such as colony 
maintenance, breed all year round, and a short generation time of 10-
12 weeks, they have serious limitations when compared with human 
populations, e.g. they do not exhibit a great variety of natural genetic 
polymorphisms12. 
A new approach to study host-parasite relationships bring out 
because no animal model was available to study the Sin Nombre virus 
(SNV), a Hantavirus which is a rodent-borne pathogen with a worldwide 
distribution and that can cause hantavirus cardiopulmonary syndrome 
(HCPS) in North America. This situation led to the experimental infection 
of the deer mouse Peromyscus maniculatus, a primary reservoir of the 
SNV8. However as in the golden hamster experimental model to study 
visceral leishmaniasis research is hindered by the lack of commercially 
available immunological and molecular reagents to investigate 
mechanisms of disease25.
In summary, we have found that both clinical and histological features 
of P. yucatanicus infected experimentally with L. (L.) mexicana resembled 
our previous studies done in patients with LCL caused by this parasite. 
Moreover parasite persistence was recorded as it has been described in 
patients where CL healed spontaneously after treatment1. These results 
support the utility of P. yucatanicus as a novel experimental model to 
study LCL caused by L. (L.) mexicana. 
RESUMEN
Estudio preliminar sobre un nuevo y original modelo experimental 
de leishmaniosis cutánea localizada causada por Leishmania 
(Leishmania) mexicana
No existe un modelo experimental de la leishmaniosis cutánea 
localizada (LCL) causada por Leishmania (Leishmania) mexicana. El 
objetivo del presente estudio fue el de caracterizar los cuadros clínico e 
histológico de Peromyscus yucatanicus infectados experimentalmente 
con L. (L.) mexicana. Un total de 54 P. yucatanicus (grupos de 18) 
fueron inoculados en la base de la cola con 1x106 promastigotes de L. (L.) 
mexicana. A los 3 y 6 meses posteriores a la infección experimental fueron 
sacrificados. El grupo control fue inoculado con RPMI-1640. El signo 
clínico predominante fue una lesión única ulcerada en 27.77% (5/18) y 
en 11.11% (2/18) P. yucatanicus a los 3 y 6 meses respectivamente. El 
patrón histológico descrito como inflamación crónica granulomatosa con 
o sin necrosis se observó en 7/7 (100%) biopsias de los P. yucatanicus a 
los 3 (n=5) y 6 (n=2) meses respectivamente. Los resultados son similares 
a los cuadros clínico e histológico de la infección por L. (L.) mexicana 
en humanos, y apoyan la posibilidad de utilizar P. yucatanicus como un 
nuevo y original modelo para el estudio de la LCL causada por L. (L.) 
mexicana.
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